Evidence map›Paper›PMID 36188240›Full record

ArticleACS omega2022

Detection of Axitinib Using Multiwalled Carbon Nanotube-Fe

Ahmet Cetinkaya, S Irem Kaya, Pelin Şenel, Nejla Cini, Esen B Atici, Sibel A Ozkan, Mine Yurtsever, Ayşegül Gölcü

Abstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ahmet CetinkayaDepartment of Analytical Chemistry, Faculty of Pharmacy, Ankara University, 06560 Ankara, Turkiye.
S Irem KayaDepartment of Analytical Chemistry, Faculty of Pharmacy, Ankara University, 06560 Ankara, Turkiye.
Pelin ŞenelChemistry Department, Science and Letters Faculty, Istanbul Technical University, Maslak, 34469 Istanbul, Turkiye.
Nejla CiniChemistry Department, Science and Letters Faculty, Istanbul Technical University, Maslak, 34469 Istanbul, Turkiye.
Esen B AticiResearch & Development Center, DEVA Holding A.S., 59520 Tekirdağ, Turkiye.
Sibel A OzkanDepartment of Analytical Chemistry, Faculty of Pharmacy, Ankara University, 06560 Ankara, Turkiye.
Mine YurtseverChemistry Department, Science and Letters Faculty, Istanbul Technical University, Maslak, 34469 Istanbul, Turkiye.ORCID https://orcid.org/0000-0001-6504-7182
Ayşegül GölcüChemistry Department, Science and Letters Faculty, Istanbul Technical University, Maslak, 34469 Istanbul, Turkiye.ORCID https://orcid.org/0000-0001-5228-1682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, axitinib (AXI), a potent and selective inhibitor of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase and used as a second-generation targeted drug, was investigated electrochemically under optimized conditions using multiwalled carbon nanotubes/iron(III) oxide nanoparticle-chitosan nanocomposite (MWCNT/Fe

Identifiers

PMID36188240
PMCPMC9520732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.